See every side of every news story
Published loading...Updated

Reimagining Continuous Manufacturing for Biologics: Beyond Perfusion to a Fully Connected Process – Contract Pharma

Summary by contractpharma.com
Continuous manufacturing (CM) has become a contentious topic in the modern pharmaceutical lexicon, driven by divergent definitions—from perfusion and flow chemistry to fully integrated systems. In biologics production, CM is an emerging technology aimed at improving yields, reducing costs, and streamlining production processes. However, despite its recent media attention, misconceptions remain about what constitutes true continuous manufacturing…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

contractpharma.com broke the news in on Friday, February 7, 2025.
Sources are mostly out of (0)